Cargando…

In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay

Lysophosphatidic acid (LPA) is a bioactive phospholipid that acts as an agonist of six G protein-coupled receptors named LPA receptors (LPA(1-6)). LPA elicits diverse intracellular events and modulates several biological functions, including cell proliferation, migration, and invasion. Overactivatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruzza, C., Argentieri, M., Ferrari, F., Armani, E., Trevisani, M., Marchini, G., Calo’, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682101/ https://www.ncbi.nlm.nih.gov/pubmed/38035009 http://dx.doi.org/10.3389/fphar.2023.1267414

Ejemplares similares

Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
por: Sturaro, Chiara, et al.
Publicado: (2022)

Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies
por: Ruzza, Chiara, et al.
Publicado: (2018)

NOP receptor pharmacological profile – A dynamic mass redistribution study
por: Malfacini, Davide, et al.
Publicado: (2018)

Ginseng pharmacology: a new paradigm based on gintonin-lysophosphatidic acid receptor interactions
por: Choi, Sun-Hye, et al.
Publicado: (2015)

A Dynamic Mass Redistribution Assay for the Human Sweet Taste Receptor Uncovers G-Protein Dependent Biased Ligands
por: Servant, Nicole B., et al.
Publicado: (2022)

In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B(2) Receptor Antagonist
por: Lesage, Anne, et al.
Publicado: (2020)

Differential Effects of Inhibitor Combinations on Lysophosphatidic Acid-Mediated Chemokine Secretion in Unprimed and Tumor Necrosis Factor-α-Primed Synovial Fibroblasts
por: Hui, Weili, et al.
Publicado: (2017)

Promising Pharmacological Directions in the World of Lysophosphatidic Acid Signaling
por: Stoddard, Nicole C., et al.
Publicado: (2015)

Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis
por: Lin, Kuan-Hung, et al.
Publicado: (2016)

Lysophosphatidic Acid–Induced EGFR Transactivation Promotes Gastric Cancer Cell DNA Replication by Stabilizing Geminin in the S Phase
por: Zhao, Haile, et al.
Publicado: (2021)

Enhancement of P2X3 Receptor-Mediated Currents by Lysophosphatidic Acid in Rat Primary Sensory Neurons
por: Qiao, Wen-Long, et al.
Publicado: (2022)

Effects of Gintonin-enriched fraction on the gene expression of six lysophosphatidic receptor subtypes
por: Lee, Rami, et al.
Publicado: (2021)

Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia Patients
por: Colom-Fernández, Beatriz, et al.
Publicado: (2019)

Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
por: Lin, Yu-Hsuan, et al.
Publicado: (2021)

The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review
por: Addis, Antonio, et al.
Publicado: (2021)

Standardizing Zebrafish Behavioral Paradigms Across Life Stages: An Effort Towards Translational Pharmacology
por: Petersen, Barbara Dutra, et al.
Publicado: (2022)

Clinical Pharmacology of Clazosentan, a Selective Endothelin A Receptor Antagonist for the Prevention and Treatment of aSAH-Related Cerebral Vasospasm
por: Juif, Pierre-Eric, et al.
Publicado: (2021)

Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and vitro assay
por: Chen, Lexian, et al.
Publicado: (2023)

Translational Pharmacology
por: Stewart, Alastair G.
Publicado: (2017)

High Expression of Lysophosphatidic Acid Induces Nerve Injury in LSS Patients via AKT Mediated NF-κB p65 Pathway
por: Zhai, Guiliang, et al.
Publicado: (2021)

Integrating Network Pharmacology and Metabolomics Study on Anti-rheumatic Mechanisms and Antagonistic Effects Against Methotrexate-Induced Toxicity of Qing-Luo-Yin
por: Zuo, Jian, et al.
Publicado: (2018)

Editorial: Network pharmacology and traditional medicine: Setting the new standards by combining In silico and experimental work
por: Wang, Xin, et al.
Publicado: (2022)

Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation
por: Wang, Zihao, et al.
Publicado: (2019)

Pharmacological Characterization of 5-Substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: Novel Antagonists for the Histamine H(3) and H(4) Receptors with Anti-inflammatory Potential
por: Corrêa, Michelle F., et al.
Publicado: (2017)

Small-Molecule Lysophosphatidic Acid Receptor 5 (LPAR5) Antagonists: Versatile Pharmacological Tools to Regulate Inflammatory Signaling in BV-2 Microglia Cells
por: Plastira, Ioanna, et al.
Publicado: (2019)

Identification of Pharmacokinetic Markers for Guanxin Danshen Drop Pills in Rats by Combination of Pharmacokinetics, Systems Pharmacology, and Pharmacodynamic Assays
por: Yao, Hong, et al.
Publicado: (2018)

TRPV1 antagonist JNJ-39439335 (mavatrep) demonstrates proof of pharmacology in healthy men: a first-in-human, double-blind, placebo-controlled, randomized, sequential group study
por: Manitpisitkul, Prasarn, et al.
Publicado: (2016)

Applicability of Generic Assays Based on Liquid Chromatography–Electrospray Mass Spectrometry to Study in vitro Metabolism of 55 Structurally Diverse Compounds
por: Rousu, Timo, et al.
Publicado: (2010)

Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors
por: Wtorek, Karol, et al.
Publicado: (2019)

In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative
por: Ruzza, Chiara, et al.
Publicado: (2015)

Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson’s Disease via Lysophosphatidic Acid Receptors
por: Choi, Jong Hee, et al.
Publicado: (2018)

Systems and in vitro pharmacology profiling of diosgenin against breast cancer
por: Khanal, Pukar, et al.
Publicado: (2023)

Benefits of a Pharmacology Antimalarial Reference Standard and Proficiency Testing Program Provided by the Worldwide Antimalarial Resistance Network (WWARN)
por: Lourens, Chris, et al.
Publicado: (2014)

Discovery of Chemical Scaffolds as Lysophosphatidic Acid Receptor 1 Antagonists: Virtual Screening, In Vitro Validation, and Molecular Dynamics Analysis
por: Nguyen, Lan Phuong, et al.
Publicado: (2023)

Methylpiperidinium Iodides as Novel Antagonists for α7 Nicotinic Acetylcholine Receptors
por: López, Jhon J., et al.
Publicado: (2018)

Is Targeting Nerve Growth Factor Antagonist a New Option for Pharmacologic Treatment of Low Back Pain? A Supplemental Network Meta-Analysis of the American College of Physicians Guidelines
por: Cao, Ziqin, et al.
Publicado: (2021)

3-OBA Is Not an Antagonist of GPR81
por: Mohammad Nezhady, Mohammad Ali, et al.
Publicado: (2022)

Pharmacological activities and gas chromatography–mass spectrometry analysis for the identification of bioactive compounds from Justicia adhatoda L.
por: Musa, Muhammad, et al.
Publicado: (2022)

The Immune System's Contribution to the Clinical Efficacy of EGFR Antagonist Treatment
por: MacDonald, Felicity, et al.
Publicado: (2017)

Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer via Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
por: Wu, Yongrong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fijgpek5spo439vr7nh379ppd9